Therapeutic areas

Cephalon focuses its R&D efforts on five main therapeutic areas:

  • Central nervous system
  • Pain
  • Oncology
  • Inflammatory diseases
  • Cardiology

Cephalon researchers use their technical expertise in medicinal chemistry, molecular and cellular biology, biochemistry, molecular and behavioural pharmacology and tumour cell biology to develop new medicines and expand indications for existing medications in an effort to bring new therapies to a greater number of patients in need.
(09/06/11)

Top page

You are now leaving www.cephalon-europe.com.


Links to site outside of Cephalon EMEA are provided as a resource to the viewer. Cephalon EMEA accepts no responsability for the content of linked sites.


OK Cancel